A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
reduce the threat of counterfeit drugs to the pharma-
ceutical supply chain, and to make the pharmaceutical 
supply chain more robust, while ensuring the authen-
ticity, content, purity, and manufacturing location and 
batch number of drugs (including COVID–19 thera-
peutics and vaccines) and allowing patient verification 
of authenticity, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
19:43 Mar 13, 2021
H1186
2 
•HR 1186 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Supply Chain Security 
2
and Pharmaceutical Authentication Act of 2021’’. 
3
SEC. 2. PACKAGES SUBJECT TO PHARMACEUTICAL DIS-
4
TRIBUTION SUPPLY CHAIN REQUIREMENTS. 
5
Subparagraph (B) of section 581(11) of the Federal 
6
Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(11)) is 
7
amended to read as follows: 
8
‘‘(B) INDIVIDUAL
SALEABLE
UNIT.—For 
9
purposes of this paragraph, an ‘individual sale-
10
able unit’ is the smallest solid oral dosage form 
11
of product, or other individual solid oral dosage 
12
form of product, introduced into commerce by 
13
the manufacturer or repackager.’’. 
14
Æ 
19:43 Mar 13, 2021
H1186
